Interleukin (IL)-33/ST2 pathway plays crucial roles in tumour growth and metastasis.
The luciferase activity was measured by a dual luciferase reporter gene assay. The allele-specific transcription factor binding for rs7025417 was examined by ChIP-seq.
The IL-33 rs7025417 CC genotype was significantly associated with a decreased rs7025417CT/CC-ST2 rs3821204GG genotypes also had a decreased risk of OS.
IL-33 mRNA and protein levels in OS patients were significantly higher than controls. Patients with the rs7025417 CC genotype exhibited lower levels of IL-33 (P = .03). The rs7025417 C allele presented a lower transcriptional activity by disrupting the binding site to c-Myb (P < .01). Moreover, the rs3821204 G/C influences the transcriptional activity and ST2 mRNA expression by altering the binding site of miR-202-3p. These findings suggest that the rs7025417 and rs3821204 may have a combined effect to protect against the development of OS by decreasing the expression levels of IL-33 or ST2.
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| INTRODUCTION
Osteosarcoma (OS) is the most common primary malignant neoplasm in bone and accounts for about 60% of all cancer-related death in children and adolescents. [1] [2] [3] Despite improvements of therapeutic strategies, the overall 5-year survival rate remains 60%-70%. [4] [5] [6] [7] Treatment often fails because of recurrent OS and/or metastasis, especially pulmonary metastasis that is the major cause of death. 5, 7 Therefore, it is vital to better understand the biological aetiology underlying the development and progression of OS. Previous studies have demonstrated some risk factors for the carcinogenesis of OS such as radiation and chemicals exposure. 8, 9 However, not all individuals develop OS when exposed to these risk factors, indicating that genetic factors may be involved in the development of OS. Our 
| MATERIALS AND METHODS

| Ethics, consent and permissions
The hospital-based case-control study was approved by the Review Boards of Affiliated Hospital of Youjiang Medical College for Nationalities. All individuals agreed to participate in the study and provided informed consent.
| Consent to publish
The participants signed the consent to publish the data.
| Study population
Totally, 402 OS patients and 572 controls were selected from the Detailed information of the study participants was described in our previous study. 11 Briefly, OS patients were diagnosed by histological examination. The following information was collected: age of diagnosis, gender, family history of cancer, tumour location and metastasis status. Patients who had a history of familial cancer were excluded from this study. The healthy controls were recruited from the same hospital with the following selection criteria: no cardiovascular diseases, hypertension, diabetes mellitus and other inflammatory diseases; no history of any cancer and no family history of any cancer.
All the participants in this study were unrelated Han Chinese.
| SNPs selection
It is well known that SNPs in the non-coding region of genes contribute to the susceptibility to OS. In this study, we selected 
| Real-time PCR
Total RNA was isolated from peripheral blood cells using a commer- 
| Plasma IL-33 levels
Plasma IL-33 concentration was measured by an enzyme-linked immunosorbent assay (Raybiotech, Norcross, GA, USA) according to the manufacturer's instructions. The minimum limit of IL-33 detection was 2 pg/mL and the maximum limit was 500 pg/mL. All experiments were done in duplicate. Plasmid containing the ST2 rs3821204 G or rs3821204 C was constructed as described previously. 22 Briefly, The 3 0 -UTR fragment of ST2 was amplified using the following primers: 
| Chromatin immunoprecipitation (ChIP) assay
The chromatin immunoprecipitation assay (ChIP) assay was performed with a commercial kit from ThermoFisher Scientific (Waltham, MA, USA) following the manufacturer's protocol. MG-63 and Saos-2 cells were cross-linked in 1% formaldehyde for 10 minutes; DNA was then subjected to immunoprecipitation using antibodies against c-Myb or non-specific rabbit IgG (Abcam). Purified DNA was amplified by PCR with the primers: 5 0 -TTGTGTCTCCTTTCCCCTACA-3 0 (forward) and 5 0 -ATGCACACCAACCACTTTGA-3 0 (reverse). PCR product was then analysed by Sanger sequencing.
| Statistical analysis
All statistical analyses were performed with the statistical software package SPSS 13.0 (SPSS Inc., Chicago, IL, USA). Continuous data, including age distribution and dual-luciferase reporter gene activities, were compared using a Student's t test. HWE and the genotype distributions of the rs7025417 and rs3821204 in cases and controls were compared using chi-squared test. Odds ratios (ORs) and 95%
confidence intervals (CIs) were computed to assess the association of the rs7025417 and rs3821204 with OS risk. Differences in plasma IL-33 levels in patients with OS and controls were analysed using a Mann-Whitney rank-sum test. Two-sided P values <.05 were considered statistically significant.
| RESULTS
| Characteristics of the study subjects
The characteristics of controls and patients with OS are shown in Table 1 with a decreased risk of OS (OR = 0.61, 95% CI, 0.43-0.87, P = .006; OR = 0.62, 95% CI, 0.43-0.90, P = .01) ( Table 3 ).
| Association between the IL-33 rs7025417 and
IL-33 mRNA and protein levels
The relative expression of IL-33 mRNA was higher in OS patients than controls (P < .001, Figure 1A ). We then analysed the correlation between the IL-33 rs7025417 and IL-33 mRNA levels. We found that the rs7025417 CC genotype was associated with a reduced IL-33 mRNA levels (P = .03, Figure 1B) . Moreover, the median levels of plasma IL-33 in OS patients was 405.3 pg/mL, which was higher than that in controls (206.9 pg/mL) (P = .01, Figure 2A ).
As shown in Figure 2B , patients with the rs7025417 CC genotype exhibited lower levels of IL-33 compared to those with the TT genotype (P = .03).
| Effect of the IL-33 rs7025417 on the transcriptional activity
To identify whether the -1611 bp polymorphism (rs7025417) in the promoter of IL-33 influenced the transcriptional activity, we constructed plasmids containing rs7025417T and rs7025417C allele and analysed the luciferase activity. As shown in Figure 3 
| IL-33 rs7025417 T allele-specific binding to transcription factor c-Myb
In silico analysis was used to predict allele-specific transcription factor binding for rs7025417, and we found that rs7025417 T to C base change might affect the binding site of c-Myb. Chip-seq was then performed to assess the validity of allele-specific transcription factor binding. As shown in Figure 4A , the DNA fractions were 
| The rs3821204 G/C influences the transcriptional activity and ST2 mRNA expression by altering the binding site of miR-202-3p
Previous study showed that the rs3821204 disrupted a miR-202-3p seeding site, resulted in an allelic difference of sST2 mRNA stability and expression, and finally modified the susceptibility of hypertension. 22 In this study, we cotransfected rs3821204 G or C plasmid 
| DISCUSSION
The hospital-based case-control study showed that the rs7025417 CC real-time PCR and ELISA showed for the first time that IL-33 mRNA and protein levels in OS patients were higher than controls. Notably, IL-33 mRNA and protein levels in patients with the rs7025417 CC genotype were lower than those with the rs7025417 TT genotype.
The dual-luciferase reporter assay showed that the rs7025417C allele presented a lower luciferase activity. ChIP assay revealed that the rs7025417 T allele can specifically bind to transcription factor c-Myb.
Additionally, the rs3821204 G/C influences the transcriptional activity and ST2 mRNA expression by altering the binding site of miR-202-3p.
These findings suggest that the rs7025417 and rs3821204 may reduce the transcriptional activity and IL-33/ST2 expression, and eventually result in the decreased risk of OS.
A possible explanation for the positive results of the IL-33CC
genotype decreasing OS risk is that the rs7025417 located in the promoter region of IL-33 and exerted influences on the transcriptional activity. In this study, the dual-luciferase gene reporter assay was performed and we found that the rs7025417 T to C shift decreased the luciferase activity. These findings were in agreement with previous results reported by Tu cotransfected with miR-202-3p mimics or negative control into HEK293 cells. Relative luciferase activity was measured using the dual luciferase reporter assay. C, miRNA-202-3p mimics or negative control was transfected into Saos-2 (rs3821204 GG) and MG-63 (rs3821204 CC) cells. Relative expression of ST2 mRNA was analysed using real-time PCR. Data were expressed by mean AE standard error (*P < .05) secretion of interferon-gamma, IL-17 and tumour necrosis factor-a, which attenuated tumour growth. 36 These findings suggest the crosstalk of IL-33 and ST2 in tumorigenesis. In this study, we found that the ORs of the combined genotypes of the 2 SNPs were lower than those of a single one in the association with OS. Further functional analysis revealed that the rs3821204 influences the transcriptional activity and ST2 mRNA levels by altering the binding site of miR-202-3p. miR-202-3p was a tumour suppressor in several cancer types, such as gastric cancer 37 and colorectal carcinoma, 38 which may be used as a target to develop novel therapeutic approaches.
Based on the results above, a conclusion was made that the IL-33 rs7025417 and ST2 rs3821204 may affect the occurrence of OS by interaction with each other in a biological way.
We have to acknowledge some limitations of this study. As is well known, genetic variants may have different effect in diverse ethnicities. In the present study, only Chinese Han was recruited, and thus our results cannot be extended directly to other ethnic groups until confirmation analysis was performed. In addition to genetic factors, environmental factors are crucial in the development and progression of OS. The study design, however, did not take them into consideration, which prevented our further interaction analysis of IL-33 and environmental factors with the risk of OS.
In conclusion, we found a functional polymorphism in the pro- 
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